BioElectronics Statistics
Total Valuation
BioElectronics has a market cap or net worth of 8.65 million.
| Market Cap | 8.65M |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
BioElectronics has 24.71 billion shares outstanding.
| Current Share Class | 24.71B |
| Shares Outstanding | 24.71B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.61% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.00% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.37 |
| PB Ratio | -0.57 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.44 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -33.67% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 2.35% |
| Revenue Per Employee | 178,829 |
| Profits Per Employee | -32,202 |
| Employee Count | 9 |
| Asset Turnover | 6.32 |
| Inventory Turnover | 9.20 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.67% in the last 52 weeks. The beta is 1.71, so BioElectronics's price volatility has been higher than the market average.
| Beta (5Y) | 1.71 |
| 52-Week Price Change | +16.67% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 54.68 |
| Average Volume (20 Days) | 11,622,196 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, BioElectronics had revenue of 1.61 million and -289,821 in losses. Loss per share was -0.00.
| Revenue | 1.61M |
| Gross Profit | 795,532 |
| Operating Income | -137,134 |
| Pretax Income | -289,821 |
| Net Income | -289,821 |
| EBITDA | n/a |
| EBIT | -137,134 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 925 in cash and 13.34 million in debt, giving a net cash position of -13.34 million or -0.00 per share.
| Cash & Cash Equivalents | 925 |
| Total Debt | 13.34M |
| Net Cash | -13.34M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -15.12M |
| Book Value Per Share | -0.00 |
| Working Capital | -5.85M |
Cash Flow
| Operating Cash Flow | -320,299 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 49.43%, with operating and profit margins of -8.52% and -18.01%.
| Gross Margin | 49.43% |
| Operating Margin | -8.52% |
| Pretax Margin | -18.01% |
| Profit Margin | -18.01% |
| EBITDA Margin | n/a |
| EBIT Margin | -8.52% |
| FCF Margin | n/a |
Dividends & Yields
BioElectronics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.11% |
| Shareholder Yield | -3.11% |
| Earnings Yield | -3.35% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BioElectronics has an Altman Z-Score of -706.67 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -706.67 |
| Piotroski F-Score | 1 |